Back To Search Results

Macrocephaly

Editor: Debopam Samanta Updated: 2/22/2026 2:11:10 PM

Introduction

Measurement of head circumference, also known as occipital frontal circumference (OFC), reflects head growth and serves as an essential tool for tracking childhood growth and neurodevelopment. On average, head circumference increases by 2 cm per month from 0 to 3 months of age and by 1 cm per month from 3 to 6 months of age. During the final 6 months of infancy, growth slows to 0.5 cm per month. Across the first year of life, head circumference increases by an average of 12 cm. After 1 year of age, head circumference increases by 1 cm every 6 months until 3 years of age and by 1 cm annually between 3 and 5 years of age, resulting in an average total gain of 5 cm from 1 to 5 years of age.

Accurate head circumference measurement may prove difficult in restless infants, particularly in the presence of thick hair, requiring careful attention to proper tape placement over anatomical landmarks. Serial measurements during each health supervision visit remain necessary through 24 to 36 months of age to evaluate head growth velocity. Frequent monitoring becomes especially important in high-risk populations, including preterm infants and children with bacterial meningitis, subdural hematoma, or hydrocephalus. Any abnormal measurement warrants confirmation through repeat assessment.

Macrocephaly describes a head circumference exceeding 2 standard deviations above the mean for gestational age and sex, corresponding to values above the 97th percentile.[1] Megalencephaly, often incorrectly used interchangeably with macrocephaly, specifically refers to increased growth of cerebral structures.[2] Macrocephaly represents a broader classification that includes megalencephaly as well as other causes of increased head size without cerebral overgrowth, eg, subdural fluid collections.

Recognition of the diverse etiologies of macrocephaly remains essential for distinguishing benign variants from conditions requiring prompt evaluation and intervention to reduce the risk of long-term neurologic impairment and developmental delay.

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

Macrocephaly describes an enlarged head size without specifying an underlying cause. Before the closure of the fontanelles and sutures in children, any increase in the volume of intracranial contents leads to an increase in head size. Etiologies include increased brain parenchyma (also termed megalencephaly) or increased cerebrospinal fluid (CSF). Additional causes include increased intracranial blood volume, thickened cranial bone, or elevated intracranial pressure from other mechanisms.

Megalencephaly

Megalencephaly may be anatomic or metabolic. Anatomic megalencephaly involves an increase in the size or number of brain cells without an associated metabolic disease, and most often follows a familial and benign pattern. Affected patients frequently present at birth with a large head and a normal-sized body, followed by rapid head growth during the first 6 months of life, with head circumference increasing by 0.6 to 1 cm per week rather than the average 0.4 cm per week. Familial megalencephaly typically results in mild macrocephaly, measuring 2 to 4 cm above the 90th percentile, with a growth curve that remains above but parallel to the 98th percentile. Family members commonly share larger-than-average head sizes.[3]

Other causes of anatomic megalencephaly vary widely and often involve genetic factors.[4] Neurocutaneous disorders, including tuberous sclerosis, neurofibromatosis, and hypomelanosis of Ito, may present with megalencephaly. Patients with autism spectrum disorder may demonstrate macrocephaly or megalencephaly, and achondroplasia may present with megalencephaly or hydrocephalus. Sotos syndrome, also referred to as cerebral gigantism, represents another cause of megalencephaly. Associated features include frontal bossing, a high forehead, a high-arched palate, intellectual disability or developmental delay, hypertelorism, and a prominent jaw or pointed chin. Most cases arise from sporadic mutations of the NSD1 gene. 

Metabolic megalencephaly involves enlargement of the brain parenchyma due to the accumulation of metabolic products within neural tissue. Conditions include leukodystrophies, eg, Alexander disease, lysosomal storage disorders, eg, Tay-Sachs disease, and organic acid disorders. Affected patients often present with a normal head circumference at birth followed by growth that exceeds the expected trajectory.[5]

Genetic Etiologies

Fragile X syndrome commonly presents with macrocephaly, intellectual disability, prominent ears and jaw, and macroorchidism, with many features becoming more apparent after puberty. The condition most frequently results from a CGG trinucleotide repeat expansion in the FMR1 gene located on the X chromosome. Nevoid basal cell carcinoma syndrome, also known as Gorlin syndrome, confers a predisposition to basal cell carcinomas and commonly presents with macrocephaly and coarse facial features. Mutations in the PTCH1 gene cause this autosomal dominant disorder.

Cowden syndrome also predisposes affected individuals to certain malignancies, including thyroid and breast cancers, and may present with macrocephaly. Mutations in the PTEN gene underlie this autosomal dominant condition. Many patients with macrocephaly harbor pathogenic genetic mutations, including those in the PPP2R5D gene.[6] Genetic disorders often demonstrate variable penetrance and expressivity, resulting in a broad spectrum of clinical manifestations.

Metabolic megalencephaly involves enlargement of the brain parenchyma due to the accumulation of metabolic products within neural tissue. Conditions include leukodystrophies, eg, Alexander disease, lysosomal storage disorders, eg, Tay-Sachs disease, and organic acid disorders. Affected patients often present with a normal head circumference at birth followed by growth that exceeds the expected trajectory.[5]

Increased Intracranial Fluid

Macrocephaly may also result from increased cerebrospinal fluid (CSF) volume. In hydrocephalus, the ventricular system contains excessive CSF, leading to ventricular dilatation and elevated intracranial pressure. Mechanisms include increased CSF production, impaired absorption, or obstruction of CSF flow. Clinical manifestations of elevated intracranial pressure include lethargy, irritability, developmental delay, nausea or vomiting, and restricted upgaze. Head enlargement may occur while cranial sutures and fontanelles remain open; loss of this compensatory capacity often necessitates surgical intervention, including placement of a ventriculoperitoneal shunt.

Elevated intracranial pressure may also result from space-occupying lesions within the cranial vault. Benign enlargement of the subarachnoid spaces represents another common CSF-related cause of macrocephaly, typically presenting within the first 6 months of life and occurring more frequently in boys than in girls. Neuroimaging demonstrates enlargement of the anterior subarachnoid spaces, distinguishing this entity from the symmetric anterior-to-posterior fluid collections associated with cerebral atrophy. Infants with this condition, particularly those born at term, typically show normal development and normal neurologic examination findings. Despite this, an increased risk of subdural hemorrhage exists even after minimal or absent trauma. Similar neuroimaging findings in infants with histories of complicated neonatal intensive care unit courses or early extracorporeal membrane oxygenation may represent a distinct subgroup associated with poorer neurologic and developmental outcomes.

Increased intracranial blood volume also contributes to enlarged head size and may result from hemorrhage or arteriovenous malformations. Hemorrhage may arise from nonaccidental trauma, prompting evaluation of social history and environmental factors. Physical examination findings may include additional injuries or retinal hemorrhages. Presentations involving intracranial hemorrhage related to nonaccidental trauma commonly include seizures, nausea or vomiting, lethargy, or irritability.

Bone Thickening

An increase in skull volume represents another cause of macrocephaly. Bone thickening may result from bone marrow expansion, as seen in thalassemia major, or from skeletal or cranial dysplasias.[7]

Epidemiology

By definition, macrocephaly is found in about 2% to 3% of the population. Large registries have reported a prevalence at birth of 18.1 per 10,000 births.[8] Although fetal growth curves are not sex-specific, in studies, male fetuses have been found to have larger head circumferences on average than females, differing by 0.3 to 0.5 standard deviations. Therefore, differing growth patterns may potentially affect the classification of microcephaly or macrocephaly, leading to underdiagnosis or overdiagnosis depending on gender.[9][1] The specifics of epidemiology, including geographic distribution, depend on the particular underlying cause. 

Pathophysiology

The pathogenesis of macrocephaly is etiology-specific, as it can result from overgrowth of the skull bones or an increase in the volume of intracranial structures, eg, CSF, blood, or brain parenchyma. Please refer to the Etiology section for more information on causes associated with macrocephaly.

History and Physical

Identification of macrocephaly requires the use of a standardized head measurement technique. Measurement involves wrapping a flexible tape around the head, positioning the tape just above the eyebrows anteriorly and over the most prominent portion of the occiput posteriorly. This measurement, known as the OFC, is plotted on the 2006 WHO international growth charts for children younger than 24 months, by age and sex, to determine the percentile rank. A head circumference at or above the 97th percentile meets criteria for macrocephaly.[10]

Evaluation of macrocephaly requires a detailed clinical history focused on birth measurements, head growth trajectory, associated medical conditions, developmental progress, and family history of macrocephaly. Particular attention should focus on prior central nervous system trauma or infection. A history of neonatal meningitis or intraventricular hemorrhage raises concern for secondary hydrocephalus and warrants close longitudinal follow-up.[11]

Physical examination, in addition to head circumference measurement and fontanelle palpation, should include assessment of overall appearance, facial features, skin findings, and a comprehensive neurologic examination to identify features suggestive of an underlying etiology or genetic syndrome. Ophthalmologic evaluation remains important, as elevated intracranial pressure may cause papilledema, although this finding may be absent in infants with open fontanelles. Additional focused examination techniques include transillumination of the calvaria, evaluation for skeletal dysplasia, and auscultation for a cranial bruit.

Evaluation

Clinical history, physical examination, and selective use of neuroimaging and genetic testing each contribute to the comprehensive evaluation of patients with macrocephaly.[2] When a patient demonstrates age-appropriate development, a neurologic examination with normal findings, no dysmorphic features suggestive of a genetic syndrome, and no family history of developmental or neurologic disorders, assessment with Weaver curves using parental head circumferences may guide interpretation. Findings within the normal range, when plotted on these curves, provide reassurance without the need for further diagnostic evaluation.[12]

Additional assessment becomes appropriate when head circumference measurements exceed the 97th percentile on standardized growth charts. Further evaluation is also warranted when serial measurements cross 1 or more major percentile lines, indicating head growth that exceeds expected velocity, or when patients younger than 6 months experience an increase in head circumference of greater than 2 cm within 1 month.

Neuroimaging plays an important role in identifying the underlying causes of macrocephaly and should follow a systematic diagnostic approach.[13] An open anterior fontanelle allows head ultrasound to serve as a simple and cost-effective initial modality for detecting intracranial abnormalities. Computed tomography offers rapid assessment but exposes infants to ionizing radiation, limiting use to situations requiring urgent information. Magnetic resonance imaging provides superior structural detail without radiation exposure, though its higher cost and the need for sedation often restrict its use.[14][15] Neuroimaging findings in benign macrocephaly commonly include dilatation of the subarachnoid spaces, with possible mild ventricular enlargement or prominence of the basilar cisterns.[16]

Treatment / Management

Management of macrocephaly depends on the underlying etiology. Presence of hydrocephalus warrants referral to neurosurgery for consideration of surgical intervention. Children with hydrocephalus accompanied by symptoms of increased ICP may require urgent neurosurgical treatment, which can prove lifesaving. Prenatal diagnosis of hydrocephalus or macrocephaly occurs in many cases.[13] Reduction of CSF volume and associated intracranial pressure may be achieved through placement of an extraventricular drain or a ventriculoperitoneal shunt.(A1)

Cases without hydrocephalus may require referral to genetics, developmental pediatrics, or pediatric neurology for further evaluation and management. Macrocephalic children with epilepsy often require treatment with antiepileptic medications. Benign familial macrocephaly generally requires no intervention beyond serial head circumference monitoring and caregiver reassurance.

Differential Diagnosis

Evaluation of an infant with macrocephaly requires careful differentiation between isolated macrocephaly and other abnormal head shapes. Plagiocephaly describes flattening of 1 region of the skull and commonly occurs in infants with a history of prolonged head positioning in a single orientation.

Craniosynostosis arises from premature fusion of cranial sutures and leads to characteristic abnormalities in skull shape. Brachycephaly results from early closure of the coronal suture and presents with a widened skull and recessed forehead. Trigonocephaly develops from the premature fusion of the metopic suture, producing a triangular-shaped forehead. Scaphocephaly occurs following early closure of the sagittal suture and presents with anterior–posterior elongation of the skull, accompanied by bitemporal narrowing.

Additional congenital skull deformities may result from traumatic forces or mechanical constraints affecting the head during intrauterine development. Such forces include multiple gestation, abnormal fetal positioning, and oligohydramnios.

Prognosis

The prognosis for macrocephaly depends on the underlying cause. When presented with an infant with otherwise normal growth and development and a normal neurologic exam, macrocephaly, by itself, is often benign, and neurodevelopmental outcomes are good.[17][18] In these cases, enlargement of the subarachnoid space may be seen on imaging. This may still be present during long-term follow-up, but no intervention is needed.[19]

Complications

Benign familial macrocephaly is not associated with any complications. However, macrocephaly due to hydrocephalus can have serious complications, including death, if not promptly treated. Other complications associated with macrocephaly are seizures, developmental disabilities, and neurologic deficits.

Deterrence and Patient Education

Effective deterrence and patient education for macrocephaly begin with empowering caregivers to understand normal head growth patterns and the importance of routine monitoring. Caregivers should be instructed on the role of OFC measurement and the significance of serial head measurements plotted on standardized growth charts. Emphasizing proper positioning during sleep and play can help prevent positional deformities, eg, plagiocephaly, while providing reassurance when head size falls within expected familial or benign growth patterns. Education should also include awareness of warning signs that warrant prompt medical evaluation, eg, rapid head growth, developmental delays, lethargy, irritability, vomiting, or abnormal neurologic findings.

Patient education also includes explaining the potential underlying causes of macrocephaly and the rationale for further evaluation when indicated. Families should understand the differences among benign familial macrocephaly, megalencephaly, hydrocephalus, and other pathologic etiologies, as well as the possible roles of neuroimaging, genetic testing, or specialty referrals. Caregivers should receive guidance on ongoing monitoring, including follow-up visits, observation for neurologic or developmental changes, and interventions when necessary, such as antiepileptic therapy, neurosurgical procedures, or referral to developmental pediatrics or genetics. Clear communication fosters informed decision-making and reduces anxiety while supporting optimal developmental and neurologic outcomes.

Enhancing Healthcare Team Outcomes

Macrocephaly, defined as a head circumference at or above the 97th percentile for age and sex, reflects abnormal or accelerated cranial growth and may arise from a variety of etiologies, including benign familial traits, megalencephaly, hydrocephalus, intracranial hemorrhage, or skeletal abnormalities. Accurate measurement of OFC, serial monitoring, and plotting on standardized growth charts are essential for early identification. Differentiating isolated macrocephaly from cranial deformities such as plagiocephaly or craniosynostosis and recognizing pathologic causes through history, physical examination, neuroimaging, and genetic testing supports timely diagnosis, appropriate intervention, and optimal neurodevelopmental outcomes.

Effective management of macrocephaly requires coordinated interprofessional care. Physicians, advanced practitioners, and general practitioners play key roles in assessment, diagnosis, and referral for neurosurgical, genetic, or developmental evaluation. Nurses and other allied health professionals support accurate measurement, monitor growth trends, and educate families on head positioning and warning signs. Pharmacists contribute to safe medication management in cases such as epilepsy. Clear communication among team members ensures coordinated care plans, timely interventions, and patient-centered education, improving safety, developmental outcomes, and overall team performance.

References


[1]

Sukenik-Halevy R, Golbary Kinory E, Laron Kenet T, Brabbing-Goldstein D, Gilboa Y, Basel-Salmon L, Perlman S. Prenatal gender-customized head circumference nomograms result in reclassification of microcephaly and macrocephaly. AJOG global reports. 2023 Feb:3(1):100171. doi: 10.1016/j.xagr.2023.100171. Epub 2023 Jan 29     [PubMed PMID: 36864987]


[2]

Accogli A, Geraldo AF, Piccolo G, Riva A, Scala M, Balagura G, Salpietro V, Madia F, Maghnie M, Zara F, Striano P, Tortora D, Severino M, Capra V. Diagnostic Approach to Macrocephaly in Children. Frontiers in pediatrics. 2021:9():794069. doi: 10.3389/fped.2021.794069. Epub 2022 Jan 14     [PubMed PMID: 35096710]


[3]

Day RE, Schutt WH. Normal children with large heads--benign familial megalencephaly. Archives of disease in childhood. 1979 Jul:54(7):512-7     [PubMed PMID: 314781]

Level 3 (low-level) evidence

[4]

Williams CA, Dagli A, Battaglia A. Genetic disorders associated with macrocephaly. American journal of medical genetics. Part A. 2008 Aug 1:146A(15):2023-37. doi: 10.1002/ajmg.a.32434. Epub     [PubMed PMID: 18629877]


[5]

Winden KD, Yuskaitis CJ, Poduri A. Megalencephaly and Macrocephaly. Seminars in neurology. 2015 Jun:35(3):277-87. doi: 10.1055/s-0035-1552622. Epub 2015 Jun 10     [PubMed PMID: 26060907]


[6]

Jiang Y, Wu B, Zhang X, Yang L, Wang S, Li H, Zhou S, Qian Y, Wang H. Thirteen New Patients of PPP2R5D Gene Mutation and the Fine Profile of Genotype-Phenotype Correlation Unraveling the Pathogenic Mechanism Underlying Macrocephaly Phenotype. Children (Basel, Switzerland). 2024 Jul 26:11(8):. doi: 10.3390/children11080897. Epub 2024 Jul 26     [PubMed PMID: 39201832]

Level 2 (mid-level) evidence

[7]

Strassburg HM. Macrocephaly is not always due to hydrocephalus. Journal of child neurology. 1989:4 Suppl():S32-40     [PubMed PMID: 2681376]


[8]

Allred RP, Aguilar-Martinez J, Howell R, Betancourt D, Marengo L, Dixon A, Jeon H, Yantz C, Kilburn M, Drummond-Borg M, Nguyen J, Arena F, Shumate C. Epidemiology of Macrocephaly in the Texas Birth Defects Registry, 1999-2019. Birth defects research. 2024 Nov:116(11):e2415. doi: 10.1002/bdr2.2415. Epub     [PubMed PMID: 39584355]


[9]

Brawley AM, Schaefer EW, Lucarelli E, Ural SH, Chuang CH, Hwang W, Paul IM, Daymont C. Differing prevalence of microcephaly and macrocephaly in male and female fetuses. Frontiers in global women's health. 2023:4():1080175. doi: 10.3389/fgwh.2023.1080175. Epub 2023 Feb 24     [PubMed PMID: 36911049]


[10]

Grummer-Strawn LM, Reinold C, Krebs NF, Centers for Disease Control and Prevention (CDC). Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2010 Sep 10:59(RR-9):1-15     [PubMed PMID: 20829749]


[11]

Lorch SA, D'Agostino JA, Zimmerman R, Bernbaum J. "Benign" extra-axial fluid in survivors of neonatal intensive care. Archives of pediatrics & adolescent medicine. 2004 Feb:158(2):178-82     [PubMed PMID: 14757610]

Level 2 (mid-level) evidence

[12]

Weaver DD, Christian JC. Familial variation of head size and adjustment for parental head circumference. The Journal of pediatrics. 1980 Jun:96(6):990-4     [PubMed PMID: 7189556]


[13]

Huang J, Sarma A, Little S, Pruthi S. Systematic Approach to Pediatric Macrocephaly. Radiographics : a review publication of the Radiological Society of North America, Inc. 2023 May:43(5):e220159. doi: 10.1148/rg.220159. Epub     [PubMed PMID: 37104125]

Level 1 (high-level) evidence

[14]

Smith R, Leonidas JC, Maytal J. The value of head ultrasound in infants with macrocephaly. Pediatric radiology. 1998 Mar:28(3):143-6     [PubMed PMID: 9561530]

Level 2 (mid-level) evidence

[15]

Sampson MA, Berg AD, Huber JN, Olgun G. Necessity of Intracranial Imaging in Infants and Children With Macrocephaly. Pediatric neurology. 2019 Apr:93():21-26. doi: 10.1016/j.pediatrneurol.2018.10.018. Epub 2018 Nov 22     [PubMed PMID: 30704866]


[16]

Alvarez LA, Maytal J, Shinnar S. Idiopathic external hydrocephalus: natural history and relationship to benign familial macrocephaly. Pediatrics. 1986 Jun:77(6):901-7     [PubMed PMID: 3714384]

Level 2 (mid-level) evidence

[17]

Biran-Gol Y, Malinger G, Cohen H, Davidovitch M, Lev D, Lerman-Sagie T, Schweiger A. Developmental outcome of isolated fetal macrocephaly. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2010 Aug:36(2):147-53. doi: 10.1002/uog.7585. Epub     [PubMed PMID: 20178112]

Level 2 (mid-level) evidence

[18]

Pettit RE, Kilroy AW, Allen JH. Macrocephaly with head growth parallel to normal growth pattern: neurological, developmental, and computerized tomography findings in full-term infants. Archives of neurology. 1980 Aug:37(8):518-21     [PubMed PMID: 7417044]

Level 3 (low-level) evidence

[19]

Gherpelli JL, Scaramuzzi V, Manreza ML, Diament AJ. Follow-up study of macrocephalic children with enlargement of the subarachnoid space. Arquivos de neuro-psiquiatria. 1992 Jun:50(2):156-62     [PubMed PMID: 1308383]